These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 31767412)

  • 1. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin.
    Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of Tilmicosin Nanostructured Lipid Carriers for Improved Oral Delivery in Broilers: Physiochemical Characterization and Cellular Permeation.
    Sahito B; Zhang Q; Yang H; Peng L; Gao X; Kashif J; Ul Aabdin Z; Jiang S; Wang L; Guo D
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31941074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Tilmicosin-Loaded Nanostructured Lipid Carriers Using Orthogonal Design for Overcoming Oral Administration Obstacle.
    Wen J; Gao X; Zhang Q; Sahito B; Si H; Li G; Ding Q; Wu W; Nepovimova E; Jiang S; Wang L; Kuca K; Guo D
    Pharmaceutics; 2021 Feb; 13(3):. PubMed ID: 33669090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
    Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
    Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical characterization and bioavailability assessment of 5-fluorouracil-based nanostructured lipid carrier (NLC): In vitro drug release, Hemolysis, and permeability modulation.
    Mainuddin ; Kumar A; Ratnesh RK; Singh J; Dumoga S; Sharma N; Jindal A
    Med Oncol; 2024 Mar; 41(5):95. PubMed ID: 38526657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers.
    Nimtrakul P; Sermsappasuk P; Tiyaboonchai W
    Drug Deliv; 2020 Dec; 27(1):1054-1062. PubMed ID: 32633144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
    Singh A; Neupane YR; Mangla B; Kohli K
    J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers for oral delivery of silymarin: Improving its absorption and in vivo efficacy in type 2 diabetes and metabolic syndrome model.
    Piazzini V; Micheli L; Luceri C; D'Ambrosio M; Cinci L; Ghelardini C; Bilia AR; Di Cesare Mannelli L; Bergonzi MC
    Int J Pharm; 2019 Dec; 572():118838. PubMed ID: 31715362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects.
    Dong Z; Iqbal S; Zhao Z
    AAPS PharmSciTech; 2020 Jan; 21(2):64. PubMed ID: 31932990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability.
    Teng Z; Yu M; Ding Y; Zhang H; Shen Y; Jiang M; Liu P; Opoku-Damoah Y; Webster TJ; Zhou J
    Int J Nanomedicine; 2019; 14():119-133. PubMed ID: 30613141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
    Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
    Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
    Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
    J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and
    Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K
    Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
    Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X
    AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W; Chen L; Huang X; Shao A
    AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of folate-mediated PEGylated nanostructured lipid carriers for the efficient delivery of furanodiene.
    Zhang J; He Y; Jiang J; Li M; Jin C; Wang L; Wang D
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1610-1618. PubMed ID: 28481661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.